Arthneeti
All Q4 FY26 results →
IP

Indian Phosphate

Q4 FY26

Indian Phosphate Q4 FY26: Revenue ₹580.25 Cr, PAT ₹13.40 Cr

Q4 FY26 investor presentation: what the company reported on revenue, margins and projects.

Price₹80
Market cap₹201 Cr
P/E9.2
Updated16 Oct 2026
Read4 min read

Based on Indian Phosphate's Q4 FY26 investor presentation. The company has not published an earnings-call transcript for this quarter, so figures here are what the investor presentation reports, not management guidance.

The short version

H2 FY26 Revenue (Consolidated): ₹580.25 Cr, up from ₹451.59 Cr in H2 FY25 — a year-on-year increase of ₹128.66 Cr. - H2 FY26 Revenue (Standalone): ₹531.16 Cr, up from ₹412.77 Cr in H2 FY25 — a year-on-year increase of ₹118.39 Cr. - Total Income H2 FY26 (Consolidated): ₹580.79 Cr vs. Quarter (H2 FY26) EBITDA: ₹25.53 Cr, up from ₹13.31 Cr in H2 FY25 (91.5% YoY increase) [Page 17] - Quarter (H2 FY26) PAT: ₹13.40 Cr, up from ₹6.51 Cr in H2 FY25 (105.7% YoY increase) [Page 17] -

From Indian Phosphate's Q4 FY26 earnings-call transcript · updated 16 Oct 2026.

Revenue & Sales Performance

  • H2 FY26 Revenue (Consolidated): ₹580.25 Cr, up from ₹451.59 Cr in H2 FY25 — a year-on-year increase of ₹128.66 Cr.
  • H2 FY26 Revenue (Standalone): ₹531.16 Cr, up from ₹412.77 Cr in H2 FY25 — a year-on-year increase of ₹118.39 Cr.
  • Total Income H2 FY26 (Consolidated): ₹580.79 Cr vs. ₹453.00 Cr in H2 FY25.
  • Total Income H2 FY26 (Standalone): ₹539.55 Cr vs. ₹413.93 Cr in H2 FY25.

2 more points from Indian Phosphate's call on revenue

Pro opens every point from 15K+ earnings calls

Profitability & Margins

See what Indian Phosphate said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

  • Manufacture of Sulphuric Acid plant at Tamil Nadu (Cuddalore) utilizing IPO proceeds; already commissioned by FY26 (Page 33, 8).
  • Backward integration into mining of rock phosphate (raw material for SSP); allotment of rock phosphate mine in Madhya Pradesh (Page 34, 8).
  • New chemical plant complex planned, land acquired at Dhule, Maharashtra for new fertilizer plant (Page 8).
  • Expansion of SSP powder and granulation capacity historically, including:
  • SSP powder expanded to 400 MT/day, SSP granulation plant set up at 200 MT/day and later expanded to 400 MT/day (Page 8).
  • Venture into manufacture of NPK complex fertilizer planned (Page 34, 8).
  • Solar plant commissioned at Bikaner (Page 8).

2 more points from Indian Phosphate's call on capex

Pro opens every point from 15K+ earnings calls

Fundraising & Capital Structure

See what Indian Phosphate said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

The investor presentation does not explicitly report any details on order book, order inflow, or pending orders. Specific mentions or figures related to these items are absent in the provided pages. - No data on order book size or status is stated. - No figures or discussions on order inflow during the periods covered. - No reference to pending orders or backlog reported. The presentation primarily focuses on financial performance, key ratios, management commentary, and shareholding patterns without mentioning order-related metrics.

Continue your research

What Indian Phosphate's management said in earlier quarters

Others in Chemicals & Petrochemicals this season

  • Vishnu Chemicals Ltd (Q4 FY26)

    Q4 FY26 Operating Revenues: ₹450.3 crore, up 14.7% YoY from ₹392.6 crore in Q4 FY25 (Page 5). Key investor presentation takeaways from Vishnu Chemicals Ltd's Q4

  • Rajputana Bio. (Q4 FY26)

    Revenue from Operations: ₹6,267.05 lakhs vs. Key investor presentation takeaways from Rajputana Bio.'s Q4 FY26 investor presentation — and how it ranks against

  • SPEB Adhesives Ltd (Q4 FY26)

    The company plans to double its manufacturing capacity, currently at about 80% utilization, with new capacity ramp-up phased over time. Key concall takeaways…

  • Chemfab Alka. (Q4 FY26)

    Chlor Alkali segment: ₹55.63 crore (down 1.21% YoY from ₹56.31 crore) . Key concall takeaways from Chemfab Alkalis Ltd's Q4 FY26 earnings call — and how it…

Compare:vs Solar Industriesvs Pidilite Inds.vs SRF Ltd

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Arthneeti Pro · Annual

Indian Phosphate and 15K+ more earnings calls,
for less than your morning chai

a day

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access

Frequently Asked Questions

What were Indian Phosphate Q4 FY26 results?

H2 FY26 Revenue (Consolidated): ₹580.25 Cr, up from ₹451.59 Cr in H2 FY25 — a year-on-year increase of ₹128.66 Cr. - H2 FY26 Revenue (Standalone): ₹531.16 Cr, up from ₹412.77 Cr in H2 FY25 — a year-on-year increase of ₹118.39 Cr. - Total Income H2 FY26 (Consolidated): ₹580.79 Cr vs. Quarter (H2 FY26) EBITDA: ₹25.53 Cr, up from ₹13.31 Cr in H2 FY25 (91.5% YoY increase) [Page 17] - Quarter (H2 FY26) PAT: ₹13.40 Cr, up from ₹6.51 Cr in H2 FY25 (105.7% YoY increase) [Page 17] -

What is Indian Phosphate share price analysis?

Indian Phosphate currently shows a neutral. The stock trades at a P/E of 9.2 with a market cap of ₹201 Cr. Investors should review the full earnings analysis for detailed insights.

Is Indian Phosphate planning capital expenditure?

Manufacture of Sulphuric Acid plant at Tamil Nadu (Cuddalore) utilizing IPO proceeds; already commissioned by FY26 (Page 33, 8).

Keep Indian Phosphate on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's investor presentation. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.